Press release
Pharmacogenomics - Top Companies Regional and Data Analysis
Pharmacogenomics Market
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Pharmacogenomics Market are:
• F. Hoffmann-la Roche Ltd
• Abbott
• Oxford Nanopore Technologies
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• QIAGEN
• Agilent Technologies, Inc.
• Myriad Genetics, Inc.
• Admera Health
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Ankit Mathur
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmacogenomics - Top Companies Regional and Data Analysis here
News-ID: 3825669 • Views: …
More Releases from The Insight Partners
Armor Materials Market Demand, Share & Growth by 2034
Armor materials are specialized substances designed to protect individuals and assets from various forms of threats, including ballistic impacts, blasts, and other hazardous conditions. These materials are utilized in a wide range of applications, including personal protective equipment, military vehicles, aerospace components, and civil infrastructure. The demand for advanced armor solutions is driven by the need for enhanced safety and security in both military and civilian contexts.
To Get Sample Copy…
Plant based Foods Market Size is Expected to Reach US$ 112.98 Billion by 2034 fr …
The Plant based Foods Market is poised for remarkable growth, driven by increasing consumer awareness regarding health, sustainability, and ethical food choices. According to the latest market research by The Insight Partners, the Plant based Foods Market is projected to grow from US$ 50.40 Billion in 2025 to US$ 112.98 Billion by 2034, registering a CAGR of 9.38% during the forecast period from 2026 to 2034. The rising popularity of…
Multivitamin Tablets and Capsules Market to Reach US$ 49.37 Billion by 2034 at a …
The multivitamin tablets and capsules market is witnessing consistent growth, driven by rising consumer awareness regarding preventive healthcare, increasing demand for dietary supplements, and expanding health and wellness trends across developed and emerging economies. According to The Insight Partners, the global multivitamin tablets and capsules market size is projected to grow from US$ 34.99 billion in 2025 to US$ 49.37 billion by 2034, registering a CAGR of 3.90% during the…
Global Green (Vegetative) Roofing Market Worth US$ 12.46 Billion by 2034, Growin …
The global Green (Vegetative) Roofing Market is poised for remarkable growth as sustainability initiatives, urban greening programs, and energy-efficient construction practices continue to gain momentum worldwide. According to the latest market analysis by The Insight Partners, the market is expected to grow from US$ 3.14 billion in 2025 to US$ 12.46 billion by 2034, registering a robust CAGR of 16.54% during the forecast period of 2026-2034.
Get Sample Copy of Report…
More Releases for Pharmacogenomics
Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market.
Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 to…
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period.
Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776
The pharmacogenomics market is segmented on the basis of…
Complete PDF Guide On Pharmacogenomics [PDF]
According to our latest study on "Pharmacogenoics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User," the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their…
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028.
The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complex…
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy.
These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certain…
Pharmacogenomics Market Worth $13.16 billion by 2029
Meticulous Research®-a leading global market research company, published a research report titled, 'Pharmacogenomics Market by Technology (PCR, Sequencing, Spectrometry, Electrophoresis), Application (Cancer, Cardiology, Neurology, Infectious Diseases), End User (Hospitals, Diagnostic Laboratories, Research Institutes)-Global Forecast to 2029.'
Download Free Research Sample @ https://www.meticulousresearch.com/download-sample-report/cp_id=5366
According to this latest publication from Meticulous Research®, the global pharmacogenomics market is projected to reach $13.16 billion by 2029, at a CAGR of 8.6% during the forecast period…
